期刊文献+

根治性宫颈切除术治疗早期宫颈癌的循证评价 被引量:3

Evidence-based evaluation of radical trachelectomy for treatment of early cervical cancer
下载PDF
导出
摘要 目的分析早期宫颈癌患者行根治性宫颈切除术(RT)和根治性全子宫切除术(RH)后5年无瘤生存率及5年总生存率(即以病人从确诊后再经治疗生存5年的病人数占同期病人总数的百万分比衡量疗效),术中和术后并发症、输血率及RT后的妊娠结局。方法应用电子计算机检索PubMed数据库,Cochrane图书馆(2014)、ISI Web of Knowledge、OVID、web.science、Ebsco-medline、超星Medalink、万方、CNKI等数据库并辅以手工检索相关期刊,截止2014年9月,共搜集相关文献325篇,对符合纳入标准的病例对照试验,分为实验组RT和对照组RH,并采用RevMan5.2软件进行Meta分析,对于无对照临床研究资料,采用描述性合并分析。结果共纳入8篇病例对照研究和45篇无对照临床研究,Meta分析结果显示RT与RH治疗早期宫颈癌的5年无瘤生存率(OR=0.94,95%CI:0.5—1.78,P=0.85)、5年总生存率(OR=0.67,95%CI:0.27—1.67,P=0.39)及术后并发症(OR=0.65,95%CI:0.41-1.02,P=0.06)差异均无统计学意义,输血率(OR=0.33,95%CI:0.21—0.51,P=0.00001)和术中并发症(OR=1.95,95%CI:1.09—3.47,P=0.02)差异均有统计学意义,即输血率较RH低,术中并发症较RH高。无对照临床病例研究文献统计学结果显示行RT后,尝试妊娠例数为504人,妊娠434例次,活产309例次,即妊娠率为86%,活产率为71%。结论RT对于有生育要求的年轻早期宫颈癌患者是一个安全有效的选择,在根除病灶的同时,又保留了患者的生育能力,且提高改善了早期宫颈癌年轻患者的生存质量。 Objective To evaluate 5-year recurrence-free survival rate, 5-year overall survival rate, intra- and post-operative complications, blood transfusion rate and the pregnancy outcomes of radical trachelectomy ( RT ) and radical hysterectomy ( RH ) for patients with early cervical cancer. Methods PubMed database, Cochrane library, ISI Web of Knowledge, OVID, Web science, Ebsco medline, super star Medalink, Wangfang data and CNKI database were searched combined with hand searching. Up to September 2014, 325 relevant articles ware collected. Case-control studies recruited were divided into experimental group RT and control group RH, and Rev Man 5.2 software was used for Meta-analysis. Descriptive analysis was used for no controlled clinical research data. Results Eight articles of case-control studies and 45 articles without controlled clinical studies were selected. Meta-analysis results showed that there were no significance differences between RT and RH in 5-year recurrence-free survival rate ( OR = 0.94,95 % CI:0. 50 - 1.78, P = 0.85 ) , 5-year overall survival rate ( OR = 0. 67, 95% CI: 0. 27-1.67,P = 0.39 ) and postoperative complications ( OR = 0. 65,95% CI: 0. 41 - 1.02, P=0.6), but that the differences in blood transfusion rate (OR = 0. 33,95% CI:O. 21 -0.51, P = 0. 00001 ) and intra-operative complications (OR = 1.95, 95% CI: 1.09 -3.47, P = 0.02) were significant. Blood transfusion rate was higher and intra-operative complication was lower with RH. Statistical results on literatures about no controlled clinical researches showed that after RT 504 cases attempted pregnancy with 434 pregnancy times. There were 309 live births with pregnancy rate of 86% and live birth rate of 71%. Conclusion RT is a safe and effective choice for young patients with early cervical cancer and fertility requirements. It can remove lesions and keep patient' s fertility, and it improves the quality of life of vounK patients with early cervical cancer.
出处 《中国妇幼健康研究》 2015年第6期1177-1184,共8页 Chinese Journal of Woman and Child Health Research
基金 国家自然科学基金资助项目(编号:8110278)
关键词 宫颈癌 根治性宫颈切除术 根治性全子宫切除术 生育能力 系统评价 cervical cancer radical trachelectomy (RT) radical hysterectomy (RH) fertility system evaluation
  • 相关文献

参考文献38

  • 1Jemal A, Bray F, Center M M, et al. Global cancer statistics[J]. CA Cancer J Clin ,2011,61 ( 2 ) :69-90.
  • 2Dargent D, Martin X, Sacchetoni A, et al. Laparoscopic vaginal radical trachelectomy:a treatment to preserve the fertility of cervical carcinoma oatients [J]. Cancer.2000.88 ( 8 ) : 1877-1882.
  • 3聂小玲,张丙忠,王继昌,徐晓武,杨洁.保留生育功能的根治性宫颈切除术的临床应用[J].浙江创伤外科,2013,18(5):684-686. 被引量:4
  • 4Covens A, Shaw P, Murphy J, et al. Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA - B carcinoma of the cervix? [J] Cance,1999,86( 11 ) :2273-2279.
  • 5Diaz J P, Sonoda Y, Leitao M M, et al. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma [J]. Gynecol Oncol, 2008,111 (2) : 255-260.
  • 6Renaud M C, Plante M, Roy M. Combined laparoscopic and vaginal radical surgery in cervical cancer [J]. Gynecol Oncol, 2000,79 ( 1 ) : 59453.
  • 7Marchiole P, Benchaib M, Buenerd A, et al. Oncological safety of laparoscopic - assisted vaginal radical trachelectomy (LARVT or Dargent' s operation) : a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH) [J]. Gynecol Oncol, 2007, 106(1): 132-141.
  • 8Park J Y, Nam J, Kim D, et al. The Comparison of Laparoscopic Radical Trachelectomy and Laparoscopic Radical Hysterectomy in Stage I131 Cervical Cancer; Surgical and Oncological Safety[J]. J Minim Invasive Gynecol,2007,14 ( 6 ) : S132.
  • 9Alexander-Sefre F, Chee N, Spencer C, et al. Surgical morbidity associated with radical trachelectomy and radical hysterectomy [J]. Gynecol Oncol,2006,101 ( 3 ) :450-454.
  • 10Beiner M E, Hanspy J, Rosen B, et al. Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: a matched case-control study [J]. Gynecol Oncol, 2008,110 (2) :168-171.

二级参考文献34

  • 1沈铿,郎景和,杨佳欣,陈亦乐,向阳,华克勤,黄惠芳,潘凌亚,吴鸣,丰有吉.腹腔镜阴式广泛性子宫颈切除术治疗早期子宫颈癌的临床分析[J].中华妇产科杂志,2006,41(4):222-225. 被引量:47
  • 2Monk BJ;Sill MW;McMeekin DS.Phase Ⅲ trial of four cisplatin-containing doublet combinations in stage ⅣB,recurrent,or persistent cervical carcinoma:a Gynecologic Oncology Group Study[J]Journal of Clinical Oncology,2009(28):4649-4655.
  • 3Moore DH;Blessing JA;McQuellon RP.Phase Ⅲ study of cisplatin with or without paclitaxel in stage ⅣB,recurrent,or persistent squamous cell carcinoma of the cervix:a gynecologic oncology group study[J]Journal of Clinical Oncology,2004(15):3113-3119.
  • 4Moore KN;Herzog TJ;Lewin S.A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage ⅣB,recurrent or persistent cervical cancer[J]Gynecologic Oncology,2007(02):299-303.
  • 5Long HJ 3rd;Bundy BN;Grendys EC Jr.Randomized phase Ⅲ trial of cisplatin with or without topotecan in carcinoma of the uterine cervix:a Gynecologic Oncology Group Study[J]Journal of Clinical Oncology,2005(21):4626-4633.
  • 6Brewer CA;Blessing JA;Nagourney RA.Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix:a phase Ⅱ study of the Gynecologic Oncology Group[J]Gynecologic Oncology,2006(02):385-388.
  • 7Weiss GR;Green S;Hannigan EV.A phase Ⅱ trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix:a Southwest Oncology Group study[J]Gynecologic Oncology,1990(03):332-336.
  • 8Kudelka AP;Winn R;Edwards CL.An update of a phase Ⅱ study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix[J]Anti-Cancer Drug Design,1997(07):657-661.
  • 9Dargent D, Brun JL, Roy M, et al. Pregnancies following radical trachelectomy for invasive cervical cancer [ J]. Gynecol Oncol, 1994,52 : 105.
  • 10Marchiole P, Benchaib M, Buenerd A, et al. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with laparoscopic- assisted vaginal radical hysterectomy ( LARVH ) [ J ]. Gynecol Onco1,2007,106 : 132-141.

共引文献30

同被引文献24

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部